Literature DB >> 25327482

Hyaluronic acid-polypyrrole nanoparticles as pH-responsive theranostics.

Dongjin Park1, Youngnam Cho, Sung-Ho Goh, Yongdoo Choi.   

Abstract

Doxorubicin-loaded hyaluronic acid-polypyrrole nanoparticles were developed for pH-responsive activatable fluorescence imaging and therapy of proliferating macrophages.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25327482     DOI： 10.1039/c4cc06349j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  19 in total

1.  Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.

Authors:  Jaehee Choi; Hyunjin Kim; Yongdoo Choi
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Theranostic Nanosystems for Targeted Cancer Therapy.

Authors:  Homan Kang; Shuang Hu; Mi Hyeon Cho; Suk Ho Hong; Yongdoo Choi; Hak Soo Choi
Journal:  Nano Today       Date:  2018-11-16       Impact factor: 20.722

3.  Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.

Authors:  Seyedmehdi Hossaini Nasr; Zahra Rashidijahanabad; Sherif Ramadan; Nate Kauffman; Narayanan Parameswaran; Kurt R Zinn; Chunqi Qian; Ripla Arora; Dalen Agnew; Xuefei Huang
Journal:  Nanoscale       Date:  2020-05-07       Impact factor: 7.790

Review 4.  Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.

Authors:  Xingshu Li; Jihoon Kim; Juyoung Yoon; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2017-03-29       Impact factor: 30.849

5.  New approach to prepare cytocompatible 3D scaffolds via the combination of sodium hyaluronate and colloidal particles of conductive polymers.

Authors:  Thanh Huong Truong; Lenka Musilová; Věra Kašpárková; Daniela Jasenská; Petr Ponížil; Antonín Minařík; Eva Korábková; Lukáš Münster; Barbora Hanulíková; Aleš Mráček; Petra Rejmontová; Petr Humpolíček
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

6.  Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.

Authors:  Manisha Pandey; Hira Choudhury; Tarakini A P Gunasegaran; Saranyah Shanmugah Nathan; Shadab Md; Bapi Gorain; Minaketan Tripathy; Zahid Hussain
Journal:  Drug Deliv Transl Res       Date:  2019-04       Impact factor: 4.617

Review 7.  Polysaccharide-based nanoparticles for theranostic nanomedicine.

Authors:  M Swierczewska; H S Han; K Kim; J H Park; S Lee
Journal:  Adv Drug Deliv Rev       Date:  2015-11-27       Impact factor: 15.470

Review 8.  Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.

Authors:  Jun Chen; Xixi Zhang; Reid Millican; Jennifer Sherwood; Sean Martin; Hanjoong Jo; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Adv Drug Deliv Rev       Date:  2021-01-09       Impact factor: 15.470

9.  Responsive alginate-cisplatin nanogels for selective imaging and combined chemo/radio therapy of proliferating macrophages.

Authors:  Suk Ho Hong; Yan Li; Joo Beom Eom; Yongdoo Choi
Journal:  Quant Imaging Med Surg       Date:  2018-09

10.  Polydopamine Nanoparticles as a Versatile Molecular Loading Platform to Enable Imaging-guided Cancer Combination Therapy.

Authors:  Ziliang Dong; Hua Gong; Min Gao; Wenwen Zhu; Xiaoqi Sun; Liangzhu Feng; Tingting Fu; Yonggang Li; Zhuang Liu
Journal:  Theranostics       Date:  2016-04-28       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.